Coral Laboratories Ltd.
Snapshot View

271.00 +9.20 ▲3.5%

30 September 2022, 04:01:00 PM
Volume: 131

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.corallab.com
Market Cap 96.44 Cr.
Enterprise Value(EV) 65.38 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 13.51 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 19.98 Trailing Twelve Months Ending 2022-06
Industry PE 31.52 Trailing Twelve Months Ending 2022-06
Book Value / Share 441.24 Trailing Twelve Months Ending 2022-06
Price to Book Value 0.61 Calculated using Price: 269.95
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 0.36 Cr. 3,572,600 Shares
FaceValue 10
Company Profile
Coral Laboratories was founded in 1994. The company is equipped with an ultra modern manufacturing unit in the state of Gujarat, Daman & today is a force to reckon with in the pharmaceutical industry; a fact which has been endorsed by the WHO GMP certification issued by the Food & Drugs Control Administration and ISO 9001-2000 Quality certification issued by American Quality Assessors.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+3.51%
1 Week
+2.96%
1 Month
+6.27%
3 Month
+14.20%
6 Month
+6.21%
1 Year
-32.11%
2 Year
-31.97%
5 Year
-69.52%
10 Year
+294.18%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 14.76 16.72 17.46 19.18 18.17 11.04 8.88 6.22 10.74
Return on Capital Employed (%) 18.70 21.24 22.22 26.93 27.23 15.91 13.44 7.86 13.53
Return on Assets (%) 11.25 13.25 14.40 15.32 14.77 9.17 7.40 5.09 8.69

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 44 51 59 70 109 116 114 116 137 156
Non Curr. Liab. 1 1 1 1 3 4 4 4 3 8
Curr. Liab. 14 9 12 18 19 20 18 25 28 26
Minority Int.
Equity & Liab. 58 61 72 89 131 140 136 144 168 190
Non Curr. Assets 24 23 22 25 58 68 52 48 57 59
Curr. Assets 34 37 50 65 74 72 84 96 111 131
Misc. Exp. not W/O
Total Assets 58 61 72 89 131 140 136 144 168 190

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 42 51 59 77 95 92 91 71 97 68
Other Income 1 1 3 3 3 4 5 6 4 5
Total Income 43 52 62 80 99 97 96 76 100 73
Total Expenditure -34 -41 -47 -61 -72 -77 -79 -65 -80 -65
PBIDT 9 11 15 19 27 20 18 11 20 8
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation -1 -1 -3 -2 -2 -2 -2 -2 -2 -2
Taxation -2 -2 -3 -5 -8 -6 -5 -2 -4 -2
Exceptional Items 0 0 1
PAT 6 8 10 12 16 12 10 7 14 5
Adjusted EPS 17 22 27 35 46 35 29 20 38 14

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 3 0 1 0 5 11 13 -1 -4 1
Cash Fr. Inv. 0 0 1 0 -3 -10 -13 3 -2 0
Cash Fr. Finan. 0 0 0 0 0 0 -3 -1 4 0
Net Change 3 1 2 0 2 1 -2 1 -2 1
Cash & Cash Eqvt 4 5 7 7 9 4 2 3 1 2

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 71.51 71.51 71.51 71.51 71.51 71.51 71.51 71.51 71.51
Public 28.49 28.49 28.49 28.49 28.49 28.49 28.49 28.49 28.49
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 30 Sep 2022
Voting Results Under Reg 44 Of SEBI LODR Regulations 2015
Pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulation) please find attached herewith the Voting Result of 40th Annual General Meeting of the members of the Company held on Friday September 29 2022 at the Registered Office of the Company SF-206 Silver Oak Complex B.P.C. Road Vadodara Gujarat- 390020 for your record.
Fri, 30 Sep 2022
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Combined Scrutinizer Report for Remote E-Voting and voting at the AGM carried out for the 40th Annual General Meeting of the Company held on Thursday September 29 2022.
Thu, 29 Sep 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulation) read with PART A and Schedule III please find enclosed herewith the proceeding of 40th Annual General Meeting of the members of the Company held on Thursday September 29 2022 at 11.00 a.m. at the Registered office of the Company at SF-206 Silver Oak Complex B.P.C. Road Vadodara Gujarat- 390020 for your records.

Technical Scans View Details >>

Fri, 30 Sep 2022
High Delivery Percentage High Delivery Percentage
High Increase 1 Month High Increase 1 Month
High Increase 3 Months High Increase 3 Months
High Decrease 1 Year High Decrease 1 Year
Closing Near 200 SMA Closing Near 200 SMA

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 227,696.89 949.00 +2.0%
Divi's Laboratories Ltd. 97,811.90 3,684.50 -0.2%
Cipla Ltd. 89,996.82 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. 72,145.56 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. 62,833.90 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. 52,506.43 1,551.40 +0.3%
Abbott India Ltd. 40,438.70 19,030.60 -0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.54 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-06 31.50 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-06 36.17 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.12 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.12 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 65.55 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-06 50.01 19,030.60 -0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.54 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-06 7.87 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-06 4.19 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.56 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.57 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.21 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-06 13.56 19,030.60 -0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-03 0.00 19,030.60 -0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 19,030.60 -0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 19,030.60 -0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 19,030.60 -0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-03 798.70 19,030.60 -0.8%

FAQ's On Coral Laboratories Ltd.

What is Coral Laboratories share price?

Can I buy Coral Laboratories shares now?

What is the Market Cap of Coral Laboratories?

What are the key metrics to analyse Coral Laboratories?

What is the 52 Week High and Low of Coral Laboratories?

What is the trend of Coral Laboratories share price?